L865-2311 Screening compound: 6-[2-oxo-2-(piperidin-1-yl)ethyl]-2-[4-(piperidine-1-carbonyl)piperidin-1-yl]-6H,7H-[1,3]thiazolo[4,5-d]pyrimidin-7-one

L865-2311 Screening compound: 6-[2-oxo-2-(piperidin-1-yl)ethyl]-2-[4-(piperidine-1-carbonyl)piperidin-1-yl]-6H,7H-[1,3]thiazolo[4,5-d]pyrimidin-7-one
L865-2311 Screening compound: 6-[2-oxo-2-(piperidin-1-yl)ethyl]-2-[4-(piperidine-1-carbonyl)piperidin-1-yl]-6H,7H-[1,3]thiazolo[4,5-d]pyrimidin-7-one alternative view

Chemical Structure Depiction of ChemDiv screening compound L865-2311
6-[2-oxo-2-(piperidin-1-yl)ethyl]-2-[4-(piperidine-1-carbonyl)piperidin-1-yl]-6H,7H-[1,3]thiazolo[4,5-d]pyrimidin-7-one

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

L865-2311

Molecular Formula

C23H32N6O3S (C23 H32 N6 O3 S)

Compound Name

6-[2-oxo-2-(piperidin-1-yl)ethyl]-2-[4-(piperidine-1-carbonyl)piperidin-1-yl]-6H,7H-[1,3]thiazolo[4,5-d]pyrimidin-7-one

IUPAC name

6-[2-oxo-2-(piperidin-1-yl)ethyl]-2-[4-(piperidine-1-carbonyl)piperidin-1-yl]-6H7H-[13]thiazolo[45-d]pyrimidin-7-one

SMILES

O=C(CN(C=Nc1c2sc(N(CC3)CCC3C(N3CCCCC3)=O)n1)C2=O)N1CCCCC1

InChI

InChI=1S/C23H32N6O3S/c30-18(26-9-3-1-4-10-26)15-29-16-24-20-19(22(29)32)33-23(25-20)28-13-7-17(8-14-28)21(31)27-11-5-2-6-12-27/h16-17H,1-15H2

InChI Key

LLMIKEGQNYFBEM-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD27482719

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

472.61

Hydrogen Bond Acceptors Count

8.00

Hydrogen Bond Donors Count

0.00

Rotatable Bond Count

6.00

Number of Nitrogen and Oxygen Atoms

9

Partition Coefficient, logP

1.905

Distribution Coefficient, logD

1.905

Water Solubility, LogSw

-2.15

Polar Surface Area

73.228

Acid Dissociation Constant (pKa)

21.78

Base Dissociation Constant (pKb)

0.70

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

69.60

L865-2311 in Drug Discovery

Included in Screening Libraries

300k Representative Compounds Library (Bemis-Murcko Clustering Algorithm) (286253 compounds)

CNS MPO Library (28609 compounds)

GPCR Targeted Library (31838 compounds)

Macl-GPIb alpha Interaction Library (22969 compounds)

Targeted Diversity Library (40567 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Nervous system
  • Musculoskeletal
  • Respiratory tract
  • Nervous system
  • Congenital
  • Skin
  • Metabolic
  • Endocrine
  • Hemic and lymphatic
  • Cardiovascular
Targets:
  • GPCR
Mechanism of action:
  • Receptor's ligands

References: we are preparing a list of scientific research reports with L865-2311 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound L865-2311?
Check Price and Availability of L865-2311, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of L865-2311 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for L865-2311
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for L865-2311
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of L865-2311 available by request